Dr. Linda A. Dimeglio, MD

  • Indianapolis, IN
  • Pediatric endocrinology physician
NPI1669587176PAC ID6103853171
Publications
171
Clinical trials
13
Industry payments
$116,430
Affiliated sites
3
Medical groups
3
Practice address
2001 W 86th St, Indianapolis, IN 46260
Practice phone
Call (317) 338-2172
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Ascension St Vincent Hospital- Indianapolis

Indianapolis, Indiana

See all 7 affiliations

Find Dr. Dimeglio's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Linda A. Dimeglio is a pediatric endocrinology physician in Indianapolis, Indiana

Dr. Dimeglio practices at Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana.

Dr. Dimeglio's NPI, 1669587176, was assigned on August 21, 2006. Dr. Dimeglio graduated from Perelman School of Medicine - Philadelphia in 1993. Dr. Dimeglio's Indiana license number on file is 01045344.

NPI and contact details
Medicare PAC ID
6103853171
NPI enumeration date
August 21, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(317) 338-2172
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Medical school graduation
1993

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Linda A. Dimeglio practices at Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana

Dr. Dimeglio's primary practice is Ascension St Vincent Hospital- Indianapolis, at 2001 W 86th St, Indianapolis, IN 46260 in Marion County. The practice phone is (317) 338-2172.

  • Ascension St Vincent Hospital- Indianapolis
    2001 W 86th St, Indianapolis, IN 46260 · Marion CountyPhone(317) 338-2172

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Linda A. Dimeglio is affiliated with 4 sites of care and 3 medical groups

Dr. Dimeglio's primary practice is Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana. The medical group on file is Deaconess Clinic. Dmand AI also links Dr. Dimeglio to 3 more group practices and clinics and 2 medical groups, each named with a free account.

See all 7 affiliations for Dr. Dimeglio

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Linda A. Dimeglio's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimeglio practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Ascension St Vincent Hospital- IndianapolisAvailable with a free account
+3 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Dimeglio practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Linda A. Dimeglio is one of 32 pediatric endocrinology physicians in Indiana

Pediatric endocrinology is Dr. Dimeglio's primary specialty in the NPI Registry, under taxonomy code 2080P0205X. Dr. Dimeglio is board certified in pediatric endocrinology by the American Board of Pediatrics. Dmand AI has Dr. Dimeglio's licenses on file in 2 states: Indiana and Illinois.

Specialties and state licenses

  • Pediatric endocrinology, IndianaPrimaryLicense 01045344 · 1996 to 2025 · taxonomy 2080P0205X
  • Illinois license1993 to 1996

Pediatric endocrinology physicians near Dr. Dimeglio

Counts of pediatric endocrinology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Linda A. Dimeglio's patients have a median age of 12

Across all payers, Dmand AI patient panel data puts Dr. Dimeglio's median patient age at 12, with 47% women.

Dr. Dimeglio's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 12

Patient panel by sex, all payers

  • Women47%
  • Men53%

Source: Dmand AI Patient Panel Data

How Dr. Linda A. Dimeglio takes part in Medicare

Dr. Dimeglio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

Dr. Linda A. Dimeglio has 171 publications on record

Dmand AI links 171 papers to Dr. Dimeglio, published from 2005 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Diabetes Mellitus, Type 1, Blood Glucose and Insulin. Dr. Dimeglio has published most often in Diabetes Care. Dr. Dimeglio's most frequent co-authors are David Matthew Maahs, MD, PhD, Desmond A. Schatz, MD and Stephen E. Gitelman, MD.

Papers171
Years published2005 to 2025

Dr. Dimeglio's papers by year, 2016 to 2025

Topics Dr. Dimeglio writes about most

  • Diabetes Mellitus, Type 1
  • Blood Glucose
  • Insulin
  • Glycated Hemoglobin
  • Hypoglycemic Agents
  • Blood Glucose Self-Monitoring
  • Insulin Infusion Systems
  • Hypoglycemia

Dr. Dimeglio's most frequent co-authors

Recent publications by Dr. Dimeglio

See all 171 publications and co-authors

See who Dr. Dimeglio researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Dimeglio works with, so you can find a warm path to the right pediatric endocrinology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Linda A. Dimeglio has worked on 13 clinical trials

Dmand AI links Dr. Dimeglio to 13 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 1, Autoimmune Diseases and Glucose Intolerance. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Dimeglio that name 3 trials.

Clinical trials with Dr. Dimeglio by phase

  1. NonePhase 1: no trials
  2. 3Phase 2: 3 trials
  3. 1Phase 2/3: 1 trial
  4. 2Phase 3: 2 trials
  5. 1Phase 4: 1 trial

Conditions in Dr. Dimeglio's trials

  • Diabetes Mellitus, Type 1
  • Autoimmune Diseases
  • Glucose Intolerance
  • Hyperglycemia
  • Osteitis Deformans

Investigators on the most trials with Dr. Dimeglio

Recent clinical trials with Dr. Dimeglio

See all 13 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Linda A. Dimeglio received $116,430 in industry payments from 2016 to 2025

CMS Open Payments shows 110 general payments to Dr. Dimeglio from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Eli Lilly and Company paid the most, $51,254. It also lists 17 research payments totaling $6,991 from 2016 to 2025, naming 3 clinical trials.

General payments to Dr. Dimeglio by program year, 2016 to 2025

General payments to Dr. Dimeglio by kind, 2016 to 2025

$116.4Kin total
  • Consulting fees$74,62064%
  • Travel and lodging$22,43319%
  • Speaker and faculty fees$15,07513%
  • Food and beverage$3,6573%
  • Other$6461%

Companies that paid Dr. Dimeglio the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Dimeglio

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Linda A. Dimeglio has 3 awards and honors on record

Dmand AI lists 3 awards for Dr. Dimeglio, most recently America's Top Doctors in 2014.

Awards and honors for Dr. Dimeglio

  1. 2014
    • America's Top Doctors
  2. 2013
    • Indianapolis Monthly
  3. Undated
    • AAP Fellow

Source: Dmand AI Professional Profile Data

Dr. Linda A. Dimeglio graduated from Perelman School of Medicine - Philadelphia

Dr. Dimeglio graduated from Perelman School of Medicine - Philadelphia in 1993. Dr. Dimeglio is a member of AAP and ENDO.

  1. Medical schoolPerelman School of Medicine - Philadelphia
  2. Board certified in pediatric endocrinologyAmerican Board of Pediatrics
  3. Board certified in pediatricsAmerican Board of Pediatrics

Source: Dmand AI Professional Profile Data

Dr. Linda A. Dimeglio accepts plans from 12 insurance carriers

Dr. Dimeglio is in network with 12 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Aspirus Health Plan
  • HCSC
  • Alliant Health Plans
  • Blue Cross and Blue Shield of Kansas City
  • +4 more carriersWith a free account

Plan types Dr. Dimeglio accepts, by number of carriers

  1. HMO7
  2. PPO7
  3. POS5
  4. EPO4
  5. Medicare2
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Linda A. Dimeglio's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Linda A. Dimeglio

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Linda A. Dimeglio's NPI number?

Dr. Linda A. Dimeglio's NPI number is 1669587176. It was assigned on August 21, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Linda A. Dimeglio?

Dr. Linda A. Dimeglio is a pediatric endocrinology physician in Indianapolis, Indiana. The primary specialty in the NPI Registry is Pediatric Endocrinology Physician (taxonomy code 2080P0205X).

Where does Dr. Linda A. Dimeglio practice?

Dr. Dimeglio practices at 2001 W 86th St, Indianapolis, IN 46260. Dr. Dimeglio's primary practice is Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana. Dmand AI also links Dr. Dimeglio to 3 group practices and clinics and 2 medical groups.

What is Dr. Linda A. Dimeglio's office phone number?

The practice phone on file for Dr. Dimeglio is (317) 338-2172.

What is Dr. Linda A. Dimeglio's medical license number?

Dr. Dimeglio's Indiana license number on file is 01045344, one of the licenses on file in 2 states.

Which states has Dr. Linda A. Dimeglio been licensed in?

Dmand AI has state licenses on file for Dr. Dimeglio in Indiana (1996 to 2025) and Illinois (1993 to 1996).

What medical group is Dr. Linda A. Dimeglio part of?

Dr. Dimeglio is linked to Deaconess Clinic. Dmand AI links Dr. Dimeglio to 2 more medical groups.

Does Dr. Linda A. Dimeglio accept Medicare?

Yes. CMS lists Dr. Dimeglio as accepting Medicare assignment.

Is Dr. Linda A. Dimeglio board certified?

Yes. Dr. Dimeglio is board certified in pediatric endocrinology by the American Board of Pediatrics.

Where did Dr. Linda A. Dimeglio go to medical school?

Dr. Dimeglio graduated from Perelman School of Medicine - Philadelphia in 1993.

Show 5 more questionsShow fewer questions

Has Dr. Linda A. Dimeglio received payments from drug or device companies?

CMS Open Payments shows $116,430 in general payments to Dr. Dimeglio from 19 companies from 2016 to 2025. The largest total came from Eli Lilly and Company.

How long has Dr. Linda A. Dimeglio been practicing?

Dr. Dimeglio graduated from medical school in 1993, 33 years ago.

Does Dr. Linda A. Dimeglio do research?

Dmand AI links 171 publications to Dr. Dimeglio, published from 2005 to 2025. Dr. Dimeglio has worked on 13 clinical trials.

Who does Dr. Linda A. Dimeglio publish with?

Dr. Dimeglio's most frequent co-authors are David Matthew Maahs, MD, PhD (14 shared papers), Desmond A. Schatz, MD (14 shared papers) and Stephen E. Gitelman, MD (13 shared papers).

What insurance does Dr. Linda A. Dimeglio accept?

Dr. Dimeglio is in network with 12 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.

Selling to pediatric endocrinology practices?

See pediatric endocrinology physicians in Indiana by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)